Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer

European Journal of Cancer

Volumn 37, Issue 8, 2001, Pages 966-971

  Vickery, C W ^a   Blazeby, J M ^a   Conroy, T ^b   Arraras, J ^c   Sezer, O ^d   Koller, M ^e   Rosemeyer, D ^f   Johnson, C D ^g   Alderson, D ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b CENTRE ALEXIS VAUTRIN   (France)

^c Universidad Pública de Navarra   (Spain)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f Klinik Rosenberg   (Germany)

^g SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

EORTC QLQ C30; EORTC QLQ STO22; Gastric neoplasm; Quality of life; Questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; EMOTION; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRE; STOMACH CANCER; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; STOMACH NEOPLASMS;

EID: 0035035740     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00417-2     Document Type: Article

References (30)

1. Carcinoma of the stomach: 10-Year survey of results and of factors affecting prognosis
2. Gastric cancer survival in Sweden. Lack of improvement in 19 years
3. Cancer of the stomach, a patient care study by the American College of Surgeons
4. Survival in stomach cancer is improving. Results of a nationwide population-based Swedish study
5. 2 resections for gastric cancer: Long-term results of the MRC randomised surgical trial
6. Extended lymph-node dissection for gastric cancer
7. Review of adjuvant chemotherapy for gastric cancer
8. Endoscopic treatment of early oesophageal or gastric cancer
9. Reconstruction after total gastrectomy by the interposition of a double jejunal pouch using a double stapling technique
10. Symptomatic outcome following resection of gastric cancer
11. Recent advances in inoperable gastric cancer chemotherapy
12. Quality of life after gastrectomy in patients with carcinoma of the stomach
13. Cost-benefit of follow-up after total gastrectomy
14. Influence of preoperative performance status on survival time of patients with advanced gastric cancer following noncurative resection
15. Combination 5-fluorouracil (FU), folinic acid (FA), and alpha-interferon 2B in advanced gastric cancer: Results of a phase II trial
16. The Sickness Impact Profile: Development and final revision of a health status measure
17. Measuring the quality of life of cancer patients: A concise QL-index for use by physicians
18. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
19. Randomised trial comparing epirubicin, cisplatin and fluorouracil versus fluorouracil, doxorubicin and methotrexate in advanced esophago-gastric cancer
20. The European Organization for Research and Treatment of Cancer approach to quality of life assessment: Guidelines for developing questionnaire modules
21. Prospective randomized trial of combined oncological therapy for gastric carcinoma
22. Importance of the duodenal passage and pouch volume after total gastrectomy and reconstruction with the Ulm pouch: Prospective randomized clinical study
23. Quality of postoperative life in gastric cancer patients seventy years of age and over
24. Palliation of patients with carcinoma of the lower oesophagus and cardia: The question of quality of life
25. Quality of life: An important endpoint both in surgical practice and research
26. Pouch versus esophagojejunostomy after total gastrectomy: A randomised clinical trial
27. Quality of life following radical surgical treatment of gastric carcinoma